These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35939328)

  • 1. Linoleic Acid-Glucosamine Hybrid for Endogenous Iron-Activated Ferroptosis Therapy in High-Grade Serous Ovarian Cancer.
    Chen Y; Liao X; Jing P; Hu L; Yang Z; Yao Y; Liao C; Zhang S
    Mol Pharm; 2022 Sep; 19(9):3187-3198. PubMed ID: 35939328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron nitroprusside as a chemodynamic agent and inducer of ferroptosis for ovarian cancer therapy.
    Asif K; Adeel M; Rahman MM; Caligiuri I; Perin T; Cemazar M; Canzonieri V; Rizzolio F
    J Mater Chem B; 2023 Apr; 11(14):3124-3135. PubMed ID: 36883303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SGK1 suppresses ferroptosis in ovarian cancer via NRF2-dependent and -independent pathways.
    Sang X; Han J; Wang Z; Cai W; Liao X; Kong Z; Yu Z; Cheng H; Liu P
    Oncogene; 2024 Nov; 43(45):3335-3347. PubMed ID: 39306614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium molybdate inhibits the growth of ovarian cancer cells via inducing both ferroptosis and apoptosis.
    Mao G; Xin D; Wang Q; Lai D
    Free Radic Biol Med; 2022 Mar; 182():79-92. PubMed ID: 35219846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucosamine reverses drug resistance in MRP2 overexpressing ovarian cancer cells.
    Valinezhad Sani F; Palizban A; Mosaffa F; Jamialahmadi K
    Eur J Pharmacol; 2020 Feb; 868():172883. PubMed ID: 31866406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letrozole may be a valuable maintenance treatment in high-grade serous ovarian cancer patients.
    Heinzelmann-Schwarz V; Knipprath Mészaros A; Stadlmann S; Jacob F; Schoetzau A; Russell K; Friedlander M; Singer G; Vetter M
    Gynecol Oncol; 2018 Jan; 148(1):79-85. PubMed ID: 29157627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verticillin A Causes Apoptosis and Reduces Tumor Burden in High-Grade Serous Ovarian Cancer by Inducing DNA Damage.
    Salvi A; Amrine CSM; Austin JR; Kilpatrick K; Russo A; Lantvit D; Calderon-Gierszal E; Mattes Z; Pearce CJ; Grinstaff MW; Colby AH; Oberlies NH; Burdette JE
    Mol Cancer Ther; 2020 Jan; 19(1):89-100. PubMed ID: 31909733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex serum immune profiling reveals circulating LAG-3 is associated with improved patient survival in high grade serous ovarian cancer.
    Eurich K; De La Cruz P; Laguna A; Woodman M; McAdams J; Lips E; Ebott J; DiSilvestro J; Ribeiro J; James N
    Gynecol Oncol; 2023 Jul; 174():200-207. PubMed ID: 37224792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer.
    Shen YT; Wang L; Evans JC; Allen C; Piquette-Miller M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical characteristics and outcomes of cases with pure ovarian clear cell, mixed type and high-grade serous adenocarcinoma.
    Kucukgoz Gulec U; Paydas S; Guzel AB; Vardar MA; Khatib G; Gumurdulu D
    Arch Gynecol Obstet; 2015 Oct; 292(4):923-9. PubMed ID: 25855053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-derived cell line models revealed therapeutic targets and molecular mechanisms underlying disease progression of high grade serous ovarian cancer.
    Kreuzinger C; von der Decken I; Wolf A; Gamperl M; Koller J; Karacs J; Pfaffinger S; Bartl T; Reinthaller A; Grimm C; Singer CF; Braicu EI; Cunnea P; Gourley C; Smeets D; Boeckx B; Lambrechts D; Perco P; Horvat R; Berns EMJJ; Cacsire Castillo-Tong D
    Cancer Lett; 2019 Sep; 459():1-12. PubMed ID: 31150822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Human p53 Adenovirus Injection (rAd-p53) Combined with Chemotherapy for 4 Cases of High-grade Serous Ovarian Cancer.
    Qu H; Xia Y; Li X
    Curr Gene Ther; 2020; 20(4):313-320. PubMed ID: 32851960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated stroma significantly contributes to the mesenchymal subtype signature of serous ovarian cancer.
    Zhang Q; Wang C; Cliby WA
    Gynecol Oncol; 2019 Feb; 152(2):368-374. PubMed ID: 30448260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma.
    Dong R; Liu X; Zhang Q; Jiang Z; Li Y; Wei Y; Li Y; Yang Q; Liu J; Wei JJ; Shao C; Liu Z; Kong B
    Oncotarget; 2014 Nov; 5(21):10816-29. PubMed ID: 25333261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer.
    Li M; Cheng X; Rong R; Gao Y; Tang X; Chen Y
    BMC Cancer; 2020 Oct; 20(1):1032. PubMed ID: 33109151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma.
    Kurimchak AM; Herrera-Montávez C; Brown J; Johnson KJ; Sodi V; Srivastava N; Kumar V; Deihimi S; O'Brien S; Peri S; Mantia-Smaldone GM; Jain A; Winters RM; Cai KQ; Chernoff J; Connolly DC; Duncan JS
    Sci Signal; 2020 Feb; 13(619):. PubMed ID: 32071169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Characterization of High-Grade Serous Ovarian Cancer: Dissecting Its Molecular Heterogeneity as a Road Towards Effective Therapeutic Strategies.
    Mittempergher L
    Curr Oncol Rep; 2016 Jul; 18(7):44. PubMed ID: 27241520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences.
    Serio PAMP; de Lima Pereira GF; Katayama MLH; Roela RA; Maistro S; Folgueira MAAK
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenesis effect of Neferine via regulating autophagy and polarization of tumor-associated macrophages in high-grade serous ovarian carcinoma.
    Zhang Q; Li Y; Miao C; Wang Y; Xu Y; Dong R; Zhang Z; Griffin BB; Yuan C; Yan S; Yang X; Liu Z; Kong B
    Cancer Lett; 2018 Sep; 432():144-155. PubMed ID: 29879497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma.
    Liu Z; Gersbach E; Zhang X; Xu X; Dong R; Lee P; Liu J; Kong B; Shao C; Wei JJ
    Mol Cancer Res; 2013 Nov; 11(11):1314-25. PubMed ID: 24045973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.